Amplimmune Inc. - Articles and news items


MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune

Industry news, News / 26 August 2013 / AstraZeneca

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune…

Daiichi Sankyo logo

Daiichi Sankyo and Amplimmune announce strategic alliance to develop AMP-110 therapy

Industry news, News / 8 January 2013 / Daiichi Sankyo

Daiichi Sankyo & Amplimmune have entered into a broad strategic collaboration…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...